[Federal Register Volume 75, Number 217 (Wednesday, November 10, 2010)]
[Notices]
[Page 69086]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-28337]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-10-10DE]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC), Agency for 
Toxic Substances and Disease Registry (ATSDR) publishes a list of 
information collection requests under review by the Office of 
management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (33 U.S.C. chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance Officer, at (404) 639-5960 or send an e-mail 
to [email protected]. Send written comments to ATSDR Desk Officer, Office of 
Management and Budget, Washington, DC 20503 or by fax to (202) 395-
5806. Written comments should be received within 30 days of this 
notice.

Proposed Project

    Creation of State and Metropolitan Area-based Surveillance Projects 
for Amyotrophic Lateral Sclerosis (ALS)--New--Agency for Toxic 
Substances and Disease Registry (ATSDR).

Background and Brief Description

    On October 10, 2008, President Bush signed S. 1382: ALS Registry 
Act which amended the Public Health Service Act to provide for the 
establishment of an Amyotrophic Lateral Sclerosis (ALS) Registry. The 
activities described are part of the effort to create the National ALS 
Registry. The purpose of the registry is to: (1) Better describe the 
incidence and prevalence of ALS in the United States; (2) examine 
appropriate factors, such as environmental and occupational, that might 
be associated with the disease; (3) better outline key demographic 
factors (such as age, race or ethnicity, gender, and family history of 
individuals diagnosed with the disease); and (4) better examine the 
connection between ALS and other motor neuron disorders that can be 
confused with ALS, misdiagnosed as ALS, and in some cases progress to 
ALS. The registry will collect personal health information that may 
provide a basis for further scientific studies of potential risks for 
developing ALS.
    This project purposes to collect information-specific data related 
to ALS. The objective of this project is to develop state-based and 
metropolitan area-based surveillance projects for ALS. The primary goal 
of the state-based and metropolitan area-based surveillance project is 
to use these data to evaluate the completeness of the National ALS 
Registry. The secondary goal of the surveillance project is to obtain 
reliable and timely information on the incidence and prevalence of ALS 
and to better describe the demographic characteristics (e.g., age, 
race, sex, and geographic location) of those with ALS.
    Neurologists or their staff will complete an ALS Case Reporting 
Form on each of their ALS patients. This will be transmitted to the 
state or metropolitan health department. The contract surveillance 
staff assigned to the state and metropolitan area health departments 
will train medical personnel how to complete the ALS Case Reporting 
Form (Attachment 3) and assist with abstracting records as requested. 
An ALS Medical Record Verification Form will be collected on a subset 
of cases reported. Each medical provider reporting source should keep a 
line listing of individuals diagnosed with or thought to have ALS along 
with information on whether or not the case was reported and if not, 
the reason. Surveillance items to be collected include information to 
make sure that there are no duplicates. There are no costs to the 
respondents other than their time. The estimated annualized burden 
hours are 703.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                                      Average
                                                                     Number of       Number of      burden per
  Type of data collection instrument       Type of respondent       respondents    responses per   response (in
                                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
Training..............................  Medical Personnel/                   243               1           30/60
                                         Neurologist.
ALS Case Reporting Form...............  Medical Personnel/                 2,250               1            5/60
                                         Neurologist.
ALS Medical Record Verification Form..  Neurologist.............             450               1           20/60
Line Listing (record keeping).........  Medical Personnel.......             243               1               1
----------------------------------------------------------------------------------------------------------------


    Dated: November 4, 2010.
Carol E. Walker,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention/Agency for Toxic Substances and Disease Registry.
[FR Doc. 2010-28337 Filed 11-9-10; 8:45 am]
BILLING CODE P